Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy

Jason V Baker, Jacqueline Neuhaus, Daniel Duprez, David A Cooper, Jennifer F Hoy, Lewis H Kuller, Fiona Lampe, Angelike P Liappis, Nina Friis-Moller, James Otvos, Nick I Paton, Russell Tracy, James D Neaton

Research output: Contribution to journalArticleResearchpeer-review

41 Citations (Scopus)


In a subgroup of participants not taking ART at study entry who were randomized in the Strategies for Management of Antiretroviral Therapy (SMART) trial to immediately initiate ART ( viral suppression group ) or to defer it ( drug conservation group ), lipoprotein particle concentrations and ApoA1 and ApoB levels were measured at baseline and at 2 and 6 months following randomization.
Original languageEnglish
Pages (from-to)2133 - 2142
Number of pages10
Issue number17
Publication statusPublished - 2011

Cite this